| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
November 3, 2026Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced U.S. FDA clearance of the Access MeMed BV® assay, a rapid host-response blood test that...
October 14, 2026Experienced global healthcare leader to accelerate innovation and expand its impact for laboratories, clinicians and patients. BREA, Calif., Oct. 14, 2026 /PRNewswire/ -- Beckman Coulter...
July 23, 2026The DxU 1800 System features new urine chemistry analyzer and consumables with market-leading microscopy helping laboratories to meet rising diagnostic demand BREA, Calif., July 23, 2026...
July 7, 2026CE-marked Access p-Tau217 blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline across Europe Brain Derived pTau217 RUO...
-
April 13, 2026
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April...
September 10, 2025Beckman Coulter Also Announces Development of Aß-42 Research Use Only Immunoassay Test BREA, Calif., Sept. 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and a leader in...
March 10, 2025The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu BREA, Calif., March 10, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...
January 28, 2025Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter's...
January 15, 2025New, Fully Automated, High-Throughput RUO Assays offered on Beckman Coulter Immunoassay Analyzers BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in...
September 17, 2024Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, today jointly announced expansion of its long-term...
July 30, 2024The collaboration aims to identify and develop accessible, minimally invasive blood-based biomarkers specific for tau pathology in the brain. These tools have the potential to be used to...
July 25, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the DxI 9000 Immunoassay Analyzer* was honored during Premier, Inc.'s annual supplier Innovation Celebration at its...
-
July 9, 2024
Ideale sia per laboratori spoke che piccoli, il nuovo analizzatore DxC 500i offre flessibilità, scalabilità e standardizzazione dei dati con un ampio menu di dosaggi di chimica clinica e...
-
July 9, 2024
Idéal pour les laboratoires périphériques ou indépendants, le nouvel analyseur DxC 500i offre une flexibilité, une évolutivité et une commutabilité des données grâce à un menu étendu...
-
July 9, 2024
Ideal para laboratorios satélites e independientes, el nuevo analizador DxC 500i ofrece flexibilidad, escalabilidad e intercambiabilidad de datos con un extenso menú de ensayos de química...
-
July 9, 2024
Das neue Analysensystem DxC 500i ist perfekt für Satelliten- und unabhängige Labore geeignet, da es Flexibilität, Skalierbarkeit und Datenaustausch bietet und gleichzeitig über ein umfassendes...
July 9, 2024Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu The New DxC...
May 29, 2024New Access NT-proBNP Assay Detects Heart Failure Biomarker in Less than 11 Minutes Patient Results Evaluated Within Context of Clinically Relevant Age-Based Cutoffs, Disease Comorbidity Data and...
May 7, 2024Beckman Coulter Now an Authorized Distributor of MeMed Key Immunoassay System and MeMed BV Assay Progress Continues on Original Collaboration to Develop a MeMed BV-Based Assay for use on Beckman...
-
April 16, 2024
Barcelona, 16 de abril de 2024 — A Beckman Coulter Diagnostics, uma das líderes mundiais em diagnósticos clínicos, anunciou hoje, antes do Congresso Europeu de Microbiologia Clínica e...
-
April 16, 2024
Barcellona, 16 aprile 2024. Beckman Coulter Diagnostics, leader nella diagnostica clinica, ha annunciato oggi, in vista del Congresso europeo di microbiologia clinica e malattie infettive...
-
April 16, 2024
Barcelona, 16 de abril de 2024: Beckman Coulter Diagnostics, uno de los líderes en diagnóstico clínico, ha anunciado hoy, con motivo del Congreso Europeo de Microbiología Clínica y...
-
April 16, 2024
Barcelona, 16. April 2024 – Beckman Coulter Diagnostics, ein führendes Unternehmen im Bereich der klinischen Diagnostik, gab heute im Vorfeld des European Society of Clinical Microbiology and...
April 16, 2024Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global), that...
March 12, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, and Fujirebio, a leader in neurological markers and In Vitro Diagnostic (IVD) manufacturing, today announced an expansion of their...
-
February 6, 2024
BREA, CALIFÓRNIA, 6 de fevereiro — A Beckman Coulter Diagnostics, uma das líderes mundiais em diagnóstico clínico, anunciou hoje a nomeação de Kevin O’Reilly como novo presidente,...
-
February 6, 2024
BREA, CALIFORNIA, 6 febbraio - Beckman Coulter Diagnostics, leader nella diagnostica clinica, ha annunciato oggi la nomina di Kevin O’Reilly a nuovo presidente, che succederà a Julie Sawyer...
-
February 6, 2024
BREA, CALIFORNIE, 6 février — Beckman Coulter Diagnostics, leader dans le domaine du diagnostic clinique, a annoncé aujourd’hui la nomination de Kevin O’Reilly au poste de président,...
-
February 6, 2024
BREA, CALIFORNIA, 6 de febrero de 2024 — Beckman Coulter Diagnostics, empresa líder en diagnóstico clínico, ha anunciado hoy el nombramiento de Kevin O'Reilly como nuevo presidente,...
February 6, 2024Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced Kevin O'Reilly's appointment as its new president succeeding Julie Sawyer Montgomery, who is now vice president and...
-
February 6, 2024
BREA, KALIFORNIEN, 6. Februar – Beckman Coulter Diagnostics, ein führendes Unternehmen der klinischen Diagnostik, gab heute die Ernennung von Kevin O’Reilly zum neuen Präsident des...
-
January 30, 2024
O novo analisador complementa os laboratórios centrais ao contribuir para o desenvolvimento das capacidades dos laboratórios satélite e de laboratórios hospitalares independentes DUBAI, 30 DE...
-
January 30, 2024
Il nuovo analizzatore completa l’offerta dei laboratori hub migliorando le capacità dei loro laboratori satellite e quelle degli ospedali indipendenti DUBAI, 30 GENNAIO 2024 - Beckman Coulter...
-
January 30, 2024
Le nouvel analyseur complète les plateaux techniques centraux en améliorant les capacités des laboratoires périphériques et des structures hospitalières indépendantes DUBAÏ, 30 JANVIER...
-
January 30, 2024
El nuevo analizador complementa los laboratorios centrales mejorando las capacidades de los laboratorios de hospitales satélite y públicos independientes DUBÁI, 30 DE ENERO DE 2024 — Beckman...
-
January 30, 2024
Das neue Analysensystem ergänzt Zentrallabore durch die Verbesserung der Leistungsfähigkeit von Satellitenlabors sowie von unabhängigen kommunalen Krankenhäusern DUBAI, 30. JANUAR 2024 – Beckman
January 29, 2024New analyzer complements hub labs by advancing capabilities of satellite and independent community hospital labs DUBAI , UAE, Jan. 29, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical...
July 25, 2023Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed,...
July 25, 2023Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical...
July 19, 2023Connecting the DxH 900 Workcell and DxH Slidemaker Stainer II with the Scopio X100HT High-throughput Digital Cell Morphology Platform Improves Lab Efficiency by Automating Hematology Workflow By...
July 17, 2023Collaboration Builds upon Fujirebio Expertise in Neurodegenerative Disease Assays and Beckman Coulter's High Sensitivity, High Throughput, Global Installed Base of Access Family of Immunoassay...
-
May 15, 2023
O analisador de imunoensaio DxI 9000 Access apresenta o maior rendimento por área ocupada da indústria: até 215 testes/hora/metro quadrado As inovações reforçam o desempenho do ensaio e a...
-
May 15, 2023
L’analizzatore per dosaggi immunometrici Access DxI 9000 vanta la più alta produttività del settore per ingombro: fino a 215 test/ora/metro quadrato Le innovazioni apportate rafforzano le...
-
May 15, 2023
L’analyseur d’immunodosage DxI 9000 Access offre une des capacités de traitement les plus élevées du marché par rapport à son encombrement : jusqu’à 215 tests/heure/mètre carré Ses...
-
May 15, 2023
El analizador de inmunoensayo DxI 9000 Access cuenta con el rendimiento por tamaño más alto de la industria: hasta 215 pruebas/hora/metro cuadrado Las innovaciones refuerzan el rendimiento del...
-
May 15, 2023
Das DxI 9000 Access-Immunassay-Analysensystem bietet den branchenweit höchsten Durchsatz pro Standfläche: Bis zu 215 Tests/Stunde/Quadratmeter Innovationen optimieren Assayleistung und...
May 15, 2023DxI 9000 Access Immunoassay Analyzer Boasts Industry's Highest Throughput per Footprint: Up To 215 Tests/Hour/Square Meter Innovations Bolster Assay Performance and Laboratory Productivity with...
-
January 31, 2023
Collaboration to Add MeMed BV to Beckman Coulter Test Menu for use on Access Family of Immunoassay Analyzers BREA, Calif. and HAIFA, Israel , Jan. 31, 2023 /PRNewswire/ -- Beckman Coulter...
-
October 11, 2022
StoCastic's TriageGo, a triage decision support tool that integrates electronic health records and emergency department workflows, will be a cornerstone of Beckman Coulter's Clinical Decision...
July 25, 2022Beckman Coulter, global leader in advanced diagnostics, today announced that it will partner with Massachusetts General Hospital to validate the use of the novel Monocyte Distribution Width (MDW)...
-
July 20, 2022
Beckman Coulter, a global leader in clinical diagnostics, and Scopio Labs, a medtech company that develops AI-powered workflow solutions, announced today a worldwide partnership to accelerate...
-
May 31, 2022
Beckman Coulter, a global clinical diagnostics leader, announces a new partnership with Germany-based company Smart4Diagnostics to close the preanalytical data gap between blood collection and...
-
March 15, 2022
O acordo de distribuição global com a Saladax Biomedical disponibiliza ensaios de monitorização de medicamentos terapêuticos antipsicóticos aos clientes da Beckman Coulter Lisboa, 15 de...
-
March 15, 2022
L’accordo con Saladax Biomedical per la distribuzione a livello mondiale porterà i test di monitoraggio per i farmaci terapeutici antipsicotici ai clienti Beckman Coulter Milano, 15 marzo 2022...
-
March 15, 2022
L'accord de distribution mondiale conclu avec Saladax Biomedical permet aux clients de Beckman Coulter d'accéder aux tests. PARIS, FRANCE, le 15 mars 2022 — Beckman Coulter, l’un des leaders...
-
March 15, 2022
Un acuerdo de distribución global con Saladax Biomedical pone a disposición de los laboratorios y profesionales sanitarios pruebas de monitorización de medicamentos antipsicóticos. Esta tecnologí
-
March 15, 2022
Global distribution agreement with Saladax Biomedical brings antipsychotic therapeutic drug monitoring assays to Beckman Coulter customers BREA, Calif. , March 15, 2022 /PRNewswire/ -- Beckman...
-
March 15, 2022
Durch die globale Vertriebsvereinbarung mit Saladax Biomedical stehen den Kunden von Beckman Coulter Tests zur Überwachung therapeutisch eingesetzter antipsychotischer Medikamente zur Verfügung. Mü
September 28, 2021Beckman Coulter today announced the launch of its DxU Iris Workcell at the AACC Annual Scientific Meeting & Clinical Lab Expo. The DxU Iris Workcell is a fully automated system that streamlines...
-
July 26, 2021
Beckman Coulter, a global clinical diagnostics leader, today announced that it has entered into definitive agreements with Quidel Corporation to obtain all rights related to the manufacture,...
May 19, 2021Beckman Coulter, a global clinical diagnostics leader, today announced the launch of Access SARS-CoV-2 IgG (1st IS), a fully-quantitative lab-based Immunoglobulin G (IgG) serology test that...
May 4, 2021Beckman Coulter, a clinical diagnostics leader, today announced the global launch of the DxA 5000 Fit, a workflow-automation solution designed to fit into medium-sized labs that run fewer than...
March 23, 2021Beckman Coulter, a clinical diagnostics leader, today announced that its Access SARS-CoV-2 IgG II antibody assay received U.S. Emergency Use Authorization (EUA) from the U.S. Food and Drug...
March 18, 2021Beckman Coulter, a clinical diagnostics leader, today announced their commitment to support the U.S. government's plan to invest more than $12 billion to expand COVID-19 testing with their...
January 25, 2021Beckman Coulter, a global leader in clinical diagnostics, announced today the launch of the DxH 560 AL, a tabletop analyzer geared to reduce the time and resource constraints faced by small to...
December 18, 2020Below is the updated press release. Beckman Coulter Launches one of the First High-Quality, High-Throughput COVID-19 Antigen Test Ideal for Mass Testing in the U.S. The Access SARS-CoV-2 Antigen...
-
November 23, 2020
Beckman Coulter, a clinical diagnostics leader, today launched its Access SARS-CoV-2 IgG II assay that measures a patient's relative level of antibodies in response to a previous SARS-CoV-2...
- November 10, 2020
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test...
October 15, 2020Beckman Coulter, a global clinical diagnostics leader, today announced that it was awarded funding by the Biomedical Advanced Research and Development Authority (BARDA) part of the office of the...
October 9, 2020Beckman Coulter, a clinical diagnostics leader, today announced its Access SARS-CoV-2 Immunoglobulin M (IgM) assay has received Emergency Use Authorization (EUA) from the U.S. Food and Drug...
October 6, 2020Beckman Coulter, a clinical diagnostics leader, today announced research results that demonstrate its Access SARS-CoV-2 IgG assay shows excellent agreement to the Genscript SARS-CoV-2 Surrogate...
October 1, 2020Beckman Coulter today announced that it has received Emergency Use Authorization (EUA) for its Access Interleukin-6 (IL-6) assay from the U.S. Food & Drug Administration (FDA). Access IL-6 is a...
August 24, 2020Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test demonstrated 99.9% specificity against...
August 5, 2020Beckman Coulter today announced new analysis from the pivotal study of its novel monocyte distribution width (MDW) hematologic biomarker for sepsis detection. The analysis showed that abnormal MDW...
July 23, 2020Beckman Coulter today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for its PK7400 Automated Microplate System and the system's reagents have...
July 21, 2020Beckman Coulter, a global leader in clinical diagnostics, announced today that it received the Scientists' Choice Award® for Best New Clinical Laboratory Instrumentation of 2019 for its DxA 5000...
July 17, 2020Beckman Coulter today announced that it received nine Clinical Laboratory Awards from IMV across five separate categories. The company's Immunoassay, Integrated Systems and Urinalysis instruments...
July 6, 2020Beckman Coulter and Lenco Diagnostic Laboratories (Lenco), one of NYC's largest privately-owned full-service reference laboratories, today announced that the first shipment of 40,000 of Beckman...
June 29, 2020Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already...
June 15, 2020La compañía ha incrementado su capacidad de fabricación y producirá 30 millones de pruebas al mes Este ensayo serológico permite detectar los anticuerpos IgG generados frente al dominio de...
- June 15, 2020
A empresa aumentou a capacidade de produção para fornecer 30 milhões de testes por mês O teste serológico deteta anticorpos IgG que visam o domínio de ligação do recetor da proteína...
- June 15, 2020
Beckman Coulter ha aumentato la capacità produttiva per raggiungere la disponibilità di 30 milioni di test al mese Il test sierologico rileva gli anticorpi IgG che riconoscono il...
- June 15, 2020
Das Unternehmen hat die Produktionskapazität zur Auslieferung von monatlich mehr als 30 Millionen Tests erhöht. Dieser serologische Test weist gegen die Rezeptor-bindende Domäne des...
- June 15, 2020
L'entreprise a augmenté sa capacité de production pour fournir 30 millions de tests par mois Le test sérologique détecte les anticorps IgG dirigés contre le domaine de liaison au récepteur...
- June 15, 2020
Brea, Calif, June 15, 2020 — Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more...
May 18, 2020Beckman Coulter announced today the availability of its DxH 690T hematology analyzer in the U.S. Designed to streamline workflow and minimize downtime in mid-volume laboratories, the DxH 690T...
-
May 15, 2020
Beckman Coulter today announced it was awarded an expanded partnership with BARDA as part of their rapidly expanding COVID-19 medical countermeasure portfolio. The partnership was awarded to...
-
April 22, 2020
Building on its strong commitment to the fight against coronavirus (COVID-19), Beckman Coulter today announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans...
-
March 31, 2020
In response to the global COVID-19 pandemic, Beckman Coulter today announced that it is developing assays to identify IgM and IgG antibodies to the coronavirus or SARS-CoV-2. The assays will be...
-
January 28, 2020
Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available for sale in the United States. The...
January 7, 2020Beckman Coulter, a global leader in clinical diagnostics, announced today that South West London Pathology (SWLP) has implemented DxH 900 haematology analysers and the Early Sepsis Indicator...
-
October 29, 2019Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract...
-
October 21, 2019
Designed for mid-volume laboratories, Beckman Coulter’s DxH 690T offers industry-leading 93% first pass yield, and includes a 5-part differential and the Early Sepsis Indicator Brea, Calif., Oct...
October 9, 2019Beckman Coulter, a global leader in clinical diagnostics, announced today that the DxA 5000 total laboratory automation solution has received FDA 510(k) clearance and is now available for sale in...
August 7, 2019Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award® for Best New Clinical...
August 6, 2019Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a RowBeckman Coulter announced that its MicroScan WalkAway family of instruments has once again received IMV ServiceTrak's "Best System Performance" award in the AST/ID category. ServiceTrak™...
August 1, 2019Beckman Coulter today announced that at the 71st Annual AACC conference it will showcase its clinical chemistry, immunoassay, hematology, urinalysis and microbiology solutions, configured in the...
-
May 2, 2019
The DxA 5000 delivers rapid and consistent turnaround time, provides the industry’s most comprehensive pre-analytical sample quality assessment and improves laboratory efficiency BREA, Calif....
April 18, 2019A major milestone on its strategic mission to lead in sepsis diagnostics, Beckman Coulter today announced that its Early Sepsis Indicator has received 510(k) clearance from the U.S. Food and Drug...
-
March 26, 2019
Le dosage Access PCT vient renforcer le plus vaste portefeuille de tests de diagnostic in vitro du secteur pour l'identification et la gestion du sepsis BREA, Californie, 26 mars 2019 /PRNewswire/ --
